A study from the Italian I-MS&RD registry provides insights into the clinical phenotype and treatment responses in patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). This research enhances understanding of these rare diseases and their management.
clinical phenotype and treatment response in aqp4 igg positive nmosd and mogad insights from the italian i ms rd registry
Original title: “Clinical phenotype and treatment response in AQP4-IgG-positive NMOSD and MOGAD: insights from the Italian I-MS&RD registry.”